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DOI 10.1186/s12887-015-0360-5RESEARCH ARTICLE Open AccessEffects of low birth weight on time to BCG
vaccination in an urban poor settlement in
Nairobi, Kenya: an observational cohort study
Martin Kavao Mutua1,4*, Rhoune Ochako6, Remare Ettarh5, Henrik Ravn2,7,8, Elizabeth Echoka3 and Peter Mwaniki4Abstract
Background: The World Health Organization recommends Bacillus Calmette-Guérin (BCG) vaccination against
tuberculosis be given at birth. However, in many developing countries, pre-term and low birth weight infants get
vaccinated only after they gain the desired weight. In Kenya, the ministry of health recommends pre-term and low
birth weight infants to be immunized at the time of discharge from hospital irrespective of their weight. This paper
seeks to understand the effects of birth weight on timing of BCG vaccine.
Methods: The study was conducted in two Nairobi urban informal settlements, Korogocho and Viwandani which
hosts the Nairobi Urban Health and Demographic Surveillance system. All infants born in the study area since
September 2006 were included in the study. Data on immunization history and birth weight of the infant were
recorded from child’s clinic card. Follow up visits were done every four months to update immunization status of
the child. A total of 3,602 infants were included in this analysis. Log normal accelerated failure time parametric
model was used to assess the association between low birth weight infants and time to BCG immunization.
Results: In total, 229 (6.4%) infants were low birth weight. About 16.6% of the low birth weight infants weighed
less than 2000 grams and 83.4% weighed between 2000 and 2490 grams. Results showed that, 60% of the low
birth weight infants received BCG vaccine after more than five weeks of life. Private health facilities were less likely
to administer a BCG vaccine on time compared to public health facilities. The effects of low birth weight on females
was 0.60 and 0.97-times that of males for infants weighing 2000–2499 grams and for infants weighing <2000 grams
respectively. The effect of low birth weight among infants born in public health facilities was 1.52 and 3.94-times that
of infants delivered in private health facilities for infants weighing 2000–2499 grams and those weighing < 2000
grams respectively.
Conclusion: Low birth weight infants received BCG immunization late compared to normal birth weight infants. Low
birth weight infants delivered in public health facilities were more likely to be immunized much later compared to
private health facilities.
Keywords: Bacillus Calmette-Guérin, Low birth weight, ImmunizationBackground
The World Health Organization (WHO) recommends
Bacillus Calmette-Guérin (BCG) immunization against
tuberculosis (TB) at birth or at first clinical contact to all
infants [1] with the exception of HIV-infected infants in
whom the BCG vaccine is associated with significant* Correspondence: mkavao@aphrc.org
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unless otherwise stated.safety concerns [2]. Approximately nine million new
cases of TB were diagnosed in 2013, with 1.5 million
deaths reported. Most of these cases and deaths oc-
curred in low and middle income countries [3], Kenya is
among the 22 high burden TB countries with an esti-
mated incident rate of 268 cases per 100,000 [3]. In
Kenya, the Ministry of Health through the Division of
Vaccines and Immunization recommends that the BCG
vaccine be given at birth or at first clinical contact, ex-
cept for pre-term and low birth weight (LBW) infantsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cinated at the time of discharge from hospital irrespect-
ive of the weight [4]. Overall, BCG coverage in Kenya is
high (96%) [5], but little is known about how soon the
vaccines should be given after birth. BCG immunization
delays have been reported in other studies [6,7] even in
settings where the coverage is high [8].
When immunization is delayed, there is an increased
risk or severity of infections during infancy due to the
shortening of the duration of the protective effect of the
vaccines [8]. Studies in West Africa have shown BCG
immunization to have beneficial non-specific effects
(NSE)–effects other than protecting the child from tuber-
culosis infections [9,10]. The earlier BCG immunization is
given to an infant the higher the chances of survival
[11-14]. While many studies have looked at timeliness of
selected vaccines, few have focused on timeliness of vac-
cine administration in African settings. Moreover limited
literature on timing of BCG among LBW infants is avail-
able. This paper, seeks to document the effects of LBW on
timeliness of BCG immunization in two urban informal
settlements in Nairobi, Kenya where healthcare access
through the public sector is limited.
Methods
Study setting
The study was carried out in two informal settlements of
Nairobi (Viwandani and Korogocho) where the African
Population and Health Research Center (APHRC) runs
the Nairobi Urban Health and Demographic Surveillance
System (NUHDSS). The NUHDSS has been in operation
since 2002 and had about 81,129 registered inhabitants in
nearly 31,977 households as of December 2012. These two
densely populated communities have high unemployment,
poverty, crime, poor sanitation and generally poorer health
indicators when compared to Nairobi as a whole [15,16].
The two communities however have notable differences:
Viwandani is bordered by an industrial area and attracts
migrant workers with relatively higher education levels,
while the population in Korogocho is more stable and shows
more co-residence of spouses. In addition, Korogocho has
less disparity with regard to gender and age distribution of
the population compared to Viwandani.
Study population
This study used maternal and child health data collected
at the NUHDSS from two periods of survey: The first
period 2007–2010 under “Urbanization, Poverty and
Health Dynamics” (UPHD) project funded by Wellcome
Trust that recruited all infants born from September 2006
and the second period 2011–2013 funded by Danish
Development Agency (DANIDA) through INDEPTH
Network and recruited infants born from January 2010. In
addition to following up infants from the first period.During both periods, mother-child pairs were recruited
and followed up with visits every four months as applic-
able. The same questionnaire was administered during
each visit by trained interviewers. Information on place of
delivery, child’s weight at birth was collected during the
first visit, while the children’s immunization history in-
cluding BCG vaccine given at birth collected during the
first three visits. A total of 8,756 infants were recruited
with 34,969 visits in total during the period of the study.
Not all infants were seen during follow up visits due var-
iety of reasons which included deaths, out migration, tem-
porary exits among others. A breakdown of the selected
sample for analysis is given in Figure 1. For this study,
3,602 infants (1668 and 1934 from first and second period)
for whom an immunization card with a valid BCG vaccine
date was seen at least once after 90 days of age and a birth
weight recorded during the first visit were included. Only
infants who had a BCG immunization and survived more
than 90 days were included in the study because they had
at least two additional opportunities where the child could
have received BCG immunization at 6 and 10 weeks old
during the child’s visit for the first and second doses of
Polio and Pentavalent immunizations.
Variables
Our outcome variable of interest is age at BCG
immunization. The weight at birth of the child (recorded
from a health card) was used as the primary exposure
variable. We defined low birth weight (LBW) and nor-
mal birth weight (NBW) as a infants weighing less than
2500 grams and more or equal to 2500 grams respectively
[17,18]. For purposes of this analysis, we sub-classified low
birth weight to those weighing below 2000 grams and those
weighing 2000–2499 grams. Other variables such as;
Mother educational level (incomplete/no education, com-
pleted primary education or secondary school or above),
Place of Delivery (Public or Private), Ethnicity (Kikuyu,
Luhya, Luo, Kamba or Others), Settlement area (Korogocho
or Viwandani), Child’s Gender (Male or Female) and Preg-
nancy Intention of the index child (Wanted the child at that
time, Wanted the child later or did not want the child at
all) were used as control variables.
Data analysis
Descriptive statistics, frequencies, proportions and me-
dian of all dependent and independent variables of inter-
est were obtained to summarize the data. The main
objective was to assess the age when a child is vacci-
nated with BCG, and compare LBW infants with the
normal birth weight infants. Approximately 1% of the in-
fants in the study received their BCG after 90 days; these
were censored at 90 days of age. Thus, Survival analysis
techniques were used to assess the time to BCG
immunization before 90 days. Kaplan-Meier curves were
Figure 1 Derivation of the sample of infants included in the study from the NUHDSS.
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the three birth weights group. Cox regression was later
used to estimate the impact of low birth weight on the
timing of the BCG immunization and identify risk fac-
tors of delay to BCG immunization; Cox models as-
sumes proportionality of the hazard function over time.
The proportionality assumption did not hold for our
data, this was deduced using the Kaplan-Meier curves
(Figure 2) and tested statistically using Schoenfeld resid-
uals. Therefore we fitted parametric regression model
methods that allow for the baseline hazards to vary for dif-
ferent categories for an independent variable and the haz-
ard function does not need to be proportional. Different
distributions for the baseline hazards were considered (ex-
ponential, Weibull, Gompertz, Lognormal, Log logistics
and gamma). Akaikes information criterion (AIC) was
used to pick the best distribution (model) which fits our
data well. The AIC suggested a log normal accelerated fail-
ure time (AFT) model. Log normal parametric model was
thus used to assess the association between LBW and time
to BCG immunization.Unadjusted (Model 1) and adjusted (Model 2) time ra-
tios (TR) were used to assess the association between
birth weight and BCG timing. Time ratio compares the
change in the survival time associated with a change in
the values of a given covariate. In an AFT model, every
subject has the same “baseline” survival curve, the covar-
iates effects serve to accelerate the passage of time.
Interaction models (Model 3 and 4) were fitted to see
how the birth weight interacts with child’s gender and
place of delivery (Public or Private Health facility)
respectively.
Ethical considerations
The study was approved by Kenya Medical Research
Institute (KEMRI) ethical review committee with annual
renewals during the second phase of the study. The re-
search assistants were trained on research ethics and ob-
tained written and verbal informed consent from all the
study respondents. The NUHDSS, on which the study
was nested, also received ethical approval from KEMRI’s
Ethical Review Board.
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Figure 2 Kaplan-Meier, Cox and lognormal curves for the different categories of the child’s birth weight.
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Descriptive statistics
A total of 229 out of 3602 infants (6.4%) included in the ana-
lysis were LBW (see Table 1). Of these, 38 (16.6%) infants
weighed below 2000 grams with a median age at BCG
immunization of 34 days interquartile range [IQR] 18–46,
191 (83.4%) weighed between 2000–2499 grams with a me-
dian immunization age of 6 days IQR 1–15. The remaining
93.6% had normal birth weight with median age of 4 days
IQR 1–10. Infants from Korogocho (52% of the sample) on
average were receiving the BCG a day later (median 5 days
IQR 1–11) than those from Viwandani (median 4 days IQR
1–10). In terms of mother’s education level, the less educated
(incomplete or no education) received the BCG vaccine a day
later as compared to those who completed primary or higher
(median 5days IQR1–12 compared to 4days IQR1–10) edu-
cation. In general, infants delivered in ahealth facility received
their BCG earlier (median 4 days IQR 1–10), as expected,
compared to infants delivered at home or by a traditional
birth attendant (median days IQR5–16).Additionally, infants
delivered at a public health facility had a median age of 1 day
IQR 1–7 compared to those delivered at a private health facil-
ity (median 6 days IQR 2–11). Males received BCG
immunization a day later (median 5 days IQR 1–11) as com-
pared to females (median 4 days IQR 1–10). About 72 infants
(2%) of all infants in the study received BCG vaccine together
with the first dose of the pentavalent vaccine. Infants who re-
ceived BCG with the first dose of pentavalent were more
likely to weigh less than 2000 grams (21%) compared to nor-
mal birth weight infants (2%) and infants weighing 2000–
2499 grams (3%). Among infants excluded from the analysis
due to lack of BCG information from their immunization
cards, 93% had normal birth weight, 4% weighed 2000–2499
grams and 3%weighed below 2000 grams.Regression analysis
The unadjusted TR shows infants with LBW tended to re-
ceive the BCG vaccinemuch later compared to the NBW in-
fants (Table 2). Infants weighing less than 2000 grams and
those weighing between 2000–2499 grams received BCG
vaccine later, TR = 7.73 [5.52, 10.82] and TR = 1.22 [0.98,
1.51] respectively when compared to normal birth weight in-
fants. Adjusting for the settlement area, ethnicity, mother’s
educational level, gender of the child, place of delivery and
whether the child was planned, the TR estimates for infants
weighing less than 2000 grams and those weighing between
2000–2499 grams became higher, 8.97 [6.01, 13.39] and 1.44
[1.15, 1.82] respectively. The effect of ethnic group of the
mother and place of delivery were also statistically signifi-
cant. Infants from other ethnic groups tend to receive BCG
vaccine much later compared to the Kikuyu. Infants deliv-
ered at a public health facility received BCG vaccine much
earlier (TR = 0.48 [0.44, 0.53]) compared to those delivered
at a private health facility. Other variables included in the
model did not attain the required level of significance.
Model 3 and 4 shows significant interactions of birth
weight with gender and place of delivery respectively. From
Table 3, the effect of low birth weight (those weighing be-
tween 2000–2499 grams) among female was 1.17 [0.89, 1.54]
which is 0.6-times that ofmales 1.95 [1.31, 2.90]. The effect of
low birth weight (those weighing <2000 grams) on female
was estimated at 8.82 [4.95, 15.71] which was 0.97-times that
of boys. Model 3 shows significant birth weight and place of
delivery interaction. The effect of low birth weight (those
weighing between 2000–2499 grams) among infants deliv-
ered in a public health facility was estimated as 1.79 [1.27,
2.54] which is 1.52-times that of infants born in a private
health facility (1.18 [0.88, 1.59]). The effect of lowbirthweight
(those weighing <2000 grams) among infants delivered in a
Table 1 Sample summary statistics
N % Median age (IQR)
of BCG vaccination
Child’s birth weight (grams)
<2000 38 1.1 34 (18–46)
2000_2499 191 5.3 6 (1–15)
> = 2500 3,373 93.6 4 (1–10)
Settlement area
Korogocho 1,881 52.2 5 (1–11)
Viwandani 1,721 47.8 4 (1–10)
Mothers level of education
Incomplete primary/no education 910 26.4 5 (1–12)
Completed primary 1,564 45.2 4 (1–10)
Secondary+ 983 28.4 4 (1–10)
Place of delivery
Non health facility 136 3.8 9 (5–16)
Health facility 3,466 96.2 4 (1–10)
Type of Health Facility
Private 2,318 67.1 6 (2–11)
Public 1,139 32.9 1 (1–7)
Child’s gender
Male 1,843 51.2 5 (1–11)
Female 1,759 48.8 4 (1–10)
Pregnancy intention for the current child
Wanted at that time 1,896 54.4 4 (1–10)
Wanted later 1,220 35 5 (1–11)
Not at all 368 10.5 5 (1–13)
Ethnic group
Kikuyu 1,094 31.6 3 (1–8)
Luhya 583 16.8 5 (1–12)
Luo 563 16.2 6 (1–12)
Kamba 712 20.6 4 (1–11)
Other 513 14.8 5 (1–12)
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20.64], 3.94-times that of low birth weight (those weigh-
ing <2000 grams) infants delivered in a private health
facility (3.66[1.78, 7.50]).
Discussion
The importance of BCG immunization in sub-Saharan
Africa remains well accepted as it is a proven and cost-
effective method of conferring immunity against tuber-
culosis and reducing the risk of outbreak of the disease.
The coverage and timeliness of immunizations are the
two key indicators of the population level protection
against specific diseases. In this study, although coverage
with BCG was above 95%, timeliness varied significantly
among specific sub-groups. We found that infants bornwith low birth weight received the BCG vaccine much
later than the normal birth weight infants. In particular,
the low birth weight (those weighing <2000 grams) in-
fants received the vaccine eight times later than the nor-
mal birth weight infants. Although there have been
concerns about administering BCG in pre-term and low
birth weight babies [19], evidence indicates a normal im-
mune response to vaccine in low birth weight infants
[20,21]. The World Health Organization recommends
that pre-term infants should be vaccinated at 40 weeks,
and this policy may underlie the delay in BCG adminis-
tration to low birth weight infants even when delivered
at full-term [22]. In Kenya, it is common practice in
health facilities to delay immunization of the low birth
weight infants, but this delay, if in excess, could have
negative health consequences especially if the infant is
exposed to tuberculosis before getting the BCG vaccine
[22]. Studies have shown that BCG also has beneficial
non-specific effects [14]. Low birth weight infants would
not benefit from these during the early part of their life,
if BCG immunization is delayed.
The tendency for late immunization among infants
from the non-Kikuyu ethnic groups in Kenya has been
reported previously and is consistent with the lower
utilization of health services among non-kikuyu ethnic
groups as observed in other studies [5,23]. Early receipt
of the BCG vaccine by infants born in public health fa-
cilities is also consistent with reports from other parts of
Sub Saharan Africa [24], which may be due to better
vaccine supply in these facilities compared to the private
health facilities in the underserved urban areas [25]. In
addition, adherence to immunization schedules is re-
quired at public health facilities and may account for the
early administration of BCG compared.
We assessed the effect of gender of the child in associ-
ation with birth weight and BCG timing; and found a
non- significant interaction, but results showed more de-
lays in males as compared to female. The reasons for the
gender difference in the timing of BCG immunization
among low birth weight infants are not clear. Further
studies are required to determine if this delay is related
to parent or caregiver choices associated with low birth
weight infants. This is important as studies in West
Africa have shown beneficial effects of BCG to be more
pronounced in female than male infants [26-28].
The interaction between birth weight and place of de-
livery where low birth weight infant delivered in public
health facilities were immunized much later compared
to their counterparts delivered from private health facil-
ities. This is in contrast to the normal birth weight in-
fants delivered from the public health facilities who get
immunized earlier. This may be due to the better trained
health workers in public health facilities intentionally
delaying BCG immunization to low birth weight infants
Table 2 Unadjusted and adjusted lognormal models estimating the effects of child birth weight on timing of the BCG
vaccination
Model 1 Model 2
Unadjusted Adjusted
Time ratio 95% CI Overall P-value Time ratio 95% CI Overall P-value
Child’s birth weight (ref: NBW (weight > =2500 grams))
2000-2499 grams 1.22 [0.98,1.51] <0.0001 1.44 [1.15,1.82] <0.0001
<2000 grams 7.73 [5.52,10.82] 8.97 [6.01,13.39]
Settlement area (ref: Korogocho)
Viwandani 0.91 [0.82,1.01] 0.079
Ethnic group (ref: Kikuyu)
Luhya 1.16 [1.02,1.32] <0.0001
Luo 1.22 [1.07,1.40]
Kamba 1.27 [1.11,1.44]
Others 1.31 [1.14,1.51]
Mother’s level of education (incomplete primary)
Completed primary 0.91 [0.81,1.02] 0.1773
Secondary+ 0.90 [0.80,1.02]
Pregnancy wanted ness (ref: wanted now)
Wanted later 1.05 [0.95,1.16] 0.1492
Not at all 1.16 [0.99,1.35]
Child’s gender (ref: male)
Female 0.95 [0.87,1.03] 0.221
Type of facility (ref: private HF)
Public HF 0.48 [0.44,0.53] <0.0001
N 3602 3185
Estimates of a significance p < 0.05 are in bold writing.
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in the slum may not do.
This study was conducted in two urban slums in the
Nairobi and may therefore be indicative of the BCG sta-
tus of low birth weight infants in similar settlements inTable 3 Interactions lognormal models estimating the effects
Model 3
HF interaction
Time ratio 95% CI
Male effect on LBW(2000–2499)
Female effect on LBW(2000–2499)
Male effect on LBW(<2000)
Female effect on LBW(<2000)
Effect of private health facility on LBW (2000–2499) 1.18 [0.88,1.59
Effect of public health facility on LBW (2000–2499) 1.79 [1.27,2.5
Effect of private health facility on LBW (<2000) 3.66 [1.78,7.5
Effect of public health facility on LBW (<2000) 14.41 [10.06,2
N 3185
Estimates of a significance p < 0.05 are in bold writing.Kenya. One limitation of the study is the large number
of infants who had to be excluded due to the absence of
documented birth weight or immunization status. The
exclusion eliminated the effects of recall bias in cases
where there is no documentation on birth weight orof child birth weight on timing of the BCG vaccination
Model 4
Sex interaction
Overall P-value Time ratio 95% CI Overall P-value
1.95 [1.31,2.90] 0.1144
1.17 [0.89,1.54]
9.10 [5.28,15.68]
8.82 [4.95,15.71]
] 0.0009
4]
0]
0.64]
3185
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further 2% were omitted from the analysis due to lack of
documentation of birth weight and/or BCG date re-
spectively. The exclusions is supplemented by the large
sample size for the analysis due to the longitudinal na-
ture of the study. In addition, the absence of information
from caregivers regarding the reasons for delays in BCG
immunization would have clarified the extent of service-
related delays.
Conclusions
This study shows that low birth weight infants in Nairobi
urban informal settlements receive BCG immunization
much later than normal birth weight infants with place of
delivery as the main factor of influence. This study con-
tributes to addressing the gap in evidence on timeliness of
immunization in urban informal settlements in Kenya as
well as other similar settings in low and middle income
countries. Additional research should be conducted to fur-
ther evaluate the timing of the other routine childhood
immunizations in similar settings as well as rural and for-
mal urban settlements. These studies should evaluate the
effects of immunization delays on overall child health.
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